Wednesday, September 16, 2009

Denver Post Editorial: Middle ground on biologic meds

Colorado BioScience Association President & CEO John Collar quoted in Sunday Denver Post editorial:

"Colorado has emerged as a center for research and development of biologics. The industry directly employs more than 21,000 Coloradans, according to John Collar, the Colorado BioScience Association's president and chief executive. Many more are employed in support jobs.

From big players like Amgen to smaller labs and medical research departments at our larger universities, biologics mean promising careers and opportunities here. As many as 650 companies, big and small, have operations in Colorado. Collar says the state now ranks fifth in the nation in attracting venture capital for biologics."

No comments:

Post a Comment